Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0066 | 0.3029 | 1 | |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0199 | 1 | 1 |
Entamoeba histolytica | steroid 5-alpha reductase, putative | 0.0199 | 1 | 1 |
Echinococcus multilocularis | 3 oxo 5 alpha steroid 4 dehydrogenase, C terminal | 0.0066 | 0.3029 | 1 |
Echinococcus granulosus | 3 oxo 5 alpha steroid 4 dehydrogenase C terminal | 0.0066 | 0.3029 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.3029 | 0.3029 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.0066 | 0.3029 | 1 |
Plasmodium vivax | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0066 | 0.3029 | 0.5 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0199 | 1 | 1 |
Giardia lamblia | Synaptic glycoprotein SC2 | 0.0066 | 0.3029 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0199 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0199 | 1 | 0.5 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0199 | 1 | 1 |
Trypanosoma brucei | 3-oxo-5-alpha-steroid 4-dehydrogenase-like, putative | 0.0199 | 1 | 1 |
Echinococcus multilocularis | synaptic glycoprotein sc2 | 0.0066 | 0.3029 | 1 |
Echinococcus granulosus | synaptic glycoprotein sc2 | 0.0066 | 0.3029 | 1 |
Leishmania major | 3-oxo-5-alpha-steroid 4-dehydrogenase-like protein | 0.0199 | 1 | 0.5 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0199 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.3029 | 0.3029 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.0199 | 1 | 1 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.0066 | 0.3029 | 1 |
Plasmodium vivax | polyprenol reductase, putative | 0.0066 | 0.3029 | 0.5 |
Plasmodium falciparum | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0066 | 0.3029 | 0.5 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0199 | 1 | 1 |
Plasmodium falciparum | polyprenol reductase, putative | 0.0066 | 0.3029 | 0.5 |
Brugia malayi | Synaptic glycoprotein SC2 | 0.0066 | 0.3029 | 0.3029 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 65 uM | Antiviral activity against HIV1 in MT4 cells | ChEMBL. | 17188402 |
EC50 (functional) | > 100 uM | Antiviral activity against HSV1 in CCL81 cells | ChEMBL. | 17188402 |
EC50 (functional) | > 100 uM | Antiviral activity against HSV2 in CCL81 cells | ChEMBL. | 17188402 |
EC50 (functional) | > 100 uM | Antiviral activity against HCMV AD169 | ChEMBL. | 17188402 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.